![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 37, 26015-26020, September 10, 1999
,
,
¶
From the
Protein Chemistry Laboratory, Department of
Molecular and Structural Biology, University of Aarhus, Science
Park, Gustav Wieds Vej 10, 8000 Aarhus C, Denmark and the
§ Department of Clinical Biochemistry, AKH Aarhus
University Hospital, Nørrebrogade 44, 8000 Aarhus C, Denmark
| |
ABSTRACT |
|---|
|
|
|---|
Transcobalamin (TC) -encoding cDNA was
isolated from a bovine mammary gland cDNA library. Hybridization of
the cloned bovine TC-cDNA to RNA samples from bovine tissues showed
that the most intensive synthesis of a TC positive 1.9-kilobase
mRNA occurred in kidney, lymphatic nodes, and liver. Bovine TC was
expressed in yeast Pichia pastoris, and the isolated
recombinant protein showed cobalamin (Cbl) and receptor binding
properties similar to TCs from other sources. Alignment of the related
Cbl carriers (haptocorrins and intrinsic factors from other species)
with bovine TC (414 residues) revealed four conservative clusters in
the sequence (85-98, 137-147, 178-190, and 268-288), which may be
responsible for Cbl binding. Three S-S bonds connected Cys residues
3-252, 98-294, and 147-190. Treatment with an S-S reducing agent
caused liberation of Cbl from TC-Cbl. A significant change was observed in the TC-Cbl absorbance spectrum upon substitution of
Co2+-coordinated H2O by azide. The reaction
developed several orders of magnitude slower, and the spectral
distortions were much stronger than those in free Cbl. This may be
caused by significant deformation of the Cbl molecule and/or by its
shielding when bound to TC.
Transcobalamin (TC)1 is
one of three proteins (TC, intrinsic factor (IF), and haptocorrin (HC))
involved in transportation and internalization of vitamin
B12 (cobalamin, Cbl) in an organism (1-4). The vitamin,
released from food in the intestine, binds to IF and enters the body by
a receptor-mediated mechanism (3, 4). The IF-Cbl complex is degraded in
lysosomes of epithelial cells of the intestine whereupon the vitamin
enters portal blood associated with TC. This carrier delivers Cbl to
different tissues where it binds to one or more specific receptors
present in the cell membrane (2, 4). A significant amount of Cbl
circulates in blood bound to HC (1, 4). The functional importance of this carrier is questionable because inherited HC deficiency does not
provoke any visible pathological effect (5) in contrast to the cases of
IF- and TC-deficiencies (6, 7). High amounts of apoHC (10-50
nM) are present in many body fluids like saliva, tears, and
milk (8, 9). However, only holo-TC has been found in bovine milk
(10).
Comparison of these proteins shows some common and some specific
features. All of them have a protein core of approximately 46 kDa,
which is heavily glycosylated for IF and HC but not for TC (1-4). The
affinity toward Cbl is supposed to be highest for HC (11, 12), though
the dissociation constants determined for Cbl binders by different
methods vary considerably (1, 4, 11, 12). The selectivity for the
"true" Cbl under competition with Cbl analogues declines in the
range IF > TC > HC (11, 14). The Cbl-binding and
receptor-binding sites are likely to be spatially separated (15,
16).
Purification of Cbl carriers is complicated by low concentration of
these proteins in natural sources (1-4). Isolation of 1 mg of TC
requires, for instance, 150-300 liters of human plasma (17, 18) or 100 liters of bovine milk (10). The available amount of pure TC is
insufficient for investigations requiring high protein quantities. An
expression system has been established for IF and TC in insect cells
(19, 20), and the recombinant proteins were obtained at the level of
10-100 µg.
We have expressed and purified recombinant bovine TC from transformed
yeast Pichia pastoris. The biological activity of the recombinant TC was confirmed by its binding to Cbl as well as to the
specific receptor in the membranes of placenta. The protein sequence
and the location of the intramolecular S-S bridges have been
established. Spectral properties of TC-Cbl with different Co2+-coordinated groups pointed to significant deformations
in the Cbl molecule and/or to its shielding from the environment when bound to TC.
Materials
All salts and materials for media were purchased from Merck,
Roche Molecular Biochemicals, Sigma, and Difco. The enzymes and kits
for DNA handling were obtained from New England Biolabs, Stratagene, and Roche Molecular Biochemicals, and the kit for polymerase chain reaction was from HT Biotechnology LTD. Membranes for
screening were from Amersham Pharmacia Biotech and Schleicher & Schuell. Oligonucleotides were synthesized by DNA technology. The yeast
expression system was purchased from Invitrogen. The affinity matrix
ProBond and anti-Myc antibody (Invitrogen) as well as Fast Flow
CM-Sepharose and Sephacryl S-200 (Amersham Pharmacia Biotech) have been
used during the protein purification.
Methods
Purification of TC and Sequence of Its Peptides--
TC was
isolated from bovine milk according to the method described earlier
(10). 100 µg of protein was treated with 2 µg of trypsin in 100 µl of 0.04 M NH3HCO3 at 37 °C
for 4 h. The peptides in 200 µl of 0.5% heptafluorobutyric acid
were applied to an HPLC column and separated by elution with a linear
gradient of 80% acetonitrile in 0.5% heptafluorobutyric acid.
Sequence of the peptides was performed on Protein Sequencer 477A
(Perkin-Elmer). Purification of rabbit TC was carried out according to
the method described elsewhere (21).
Preparation of Oligonucleotides and DNA Probes--
TC-specific
oligonucleotides (20-mers) were synthesized on the basis of the amino
acid sequence of the bovine TC fragments: NI(C)EITE, (C)VHQKRV,
GYFGNVY, KSYVDLI, and EDILKNA. Human TC-cDNA was kindly provided by
Dr. E. V. Quadros. The sequence of oligonucleotides for Isolation of TC-encoding Clones and DNA Sequence--
A mammary
gland cDNA library cloned in vector Northern Blot of RNA from Bovine Tissues--
Total RNA was
isolated from different bovine tissues by ultracentrifugation in CsCl
and blotted on a nitrocellulose membrane according to the standard
recommendations (22). Hybridization was performed with a
32P-labeled bovine TC cDNA probe and the probe for
Construction of the Expression Vector--
The cDNA encoding
the mature TC was amplified by polymerase chain reaction from pBS-TC
construction using the primers with NotI and SpeI
adaptors. The polymerase chain reaction product was ligated at
NotI and SpeI sites to the expression plasmid
pPICZ Expression of the Recombinant Bovine TC in Yeast P. pastoris--
The expression scheme followed the general
recommendations of the manufacturer (Invitrogen). The verified pPIC-TC
construction was linearized inside the alcohol oxidase 1 promoter by
treatment with endonuclease NsiI. The methanol-metabolizing
Mut+ strain SMD 1168 of P. pastoris was
transformed by electroporation and plated. The cell line with the
highest level of TC synthesis was established during trial expressions.
The recombinant yeast was grown for 2 days in 1 liter of buffered
glycerol complex medium supplemented with 1% casamino acids and 0.5 µM aqua Cbl. Then, the cells were pelleted and
resuspended in 1 liter of induction medium (buffered methanol complex
medium) containing the same additives and 1% methanol. The growth was continued for 24 h. Afterward, the suspension was centrifuged, and
the cell-free supernatant was used for isolation of the recombinant bovine TC.
Purification of the Recombinant Bovine TC--
Proteins in the
obtained supernatant were precipitated by ammonium sulfate at 70% of
saturation. The pellet was dissolved in 20 ml of 0.02 M
Pi buffer, pH 7.5, and the protein solution was dialyzed
against 3 liters of the same buffer overnight at 5 °C. Then, TC was
adsorbed on 2 ml of CM-Sepharose at room temperature and washed in the
column by increasing concentrations of Pi buffer: 0.02 M, 0.05 M, 0.1 M (pH 7.5). The
protein was eluted with 2 ml of 0.5 M Pi
buffer, pH 7.5, and the collected sample contained approximately 1 mg
of the fusion protein mHX-TC. The sample was treated with 30 µg of
factor Xa for 30 h at 37 °C to remove the service
peptides from the N terminus. The preparation was applied to a 250-ml
Sephacryl S-200 column equilibrated with 0.1 M Tris, 1 M NaCl, pH 8.0, at room temperature. The eluted fractions
with maximal specific Cbl adsorption at 362 nm were pooled, dialyzed against 0.02 M Pi buffer, pH 7.5, and
concentrated by adsorption on a small CM-Sepharose column (0.3 ml) as
described above. The final preparation was stored frozen.
Spectral Measurements--
The spectra of TC-Cbl were recorded
on a M350 double beam spectrophotometer (Camspec). The TC concentration
was measured at 205 nm according to the peptide bond adsorption (23)
and used for estimation of an approximate extinction coefficient of
TC-Cbl-OH2 at 362 nm:
E362(mg/ml)
Substitution of the Co2+-coordinated
Substitution of Determination of Endogenous Cbl and Cbl Binding
Capacity--
The amount of TC-bound Cbl was measured either by the
extinction coefficient
Concentration of apoTC was determined by incubation with an excess of
[57Co]Cbl followed by adsorption of unbound radioactive
ligand on hemoglobin-coated charcoal (25). The assay was performed in an albumin solution containing 1 M NaCl to prevent
artificial adsorption of bovine TC-[57Co]Cbl on charcoal.
Determination of the Rate Constant for TC-Cbl
Dissociation--
Recombinant bovine TC was depleted of endogenous Cbl
by dialysis against 8 M urea as described earlier (10, 13),
and Cbl binding capacity in the obtained preparation was measured. The preparation of apoTC (1 nM) was exposed to 0.9 nM [57Co]Cbl in the incubation solution (0.1 M Pi buffer, pH 8.0, 1 M NaCl, 1 mg/ml human serum albumin) for 1 h at room temperature. Afterward,
the sample was diluted 1:1 with the same buffer (with or without 1 µM unlabeled cyano-Cbl) and incubated at 37 °C for 30 h. The remaining protein-associated [57Co]Cbl was
measured as a function of time.
Binding of Bovine TC-Cbl to the TC Receptor in Human
Placenta--
The radioactive tracer, containing partially purified
human TC-[57Co]Cbl, was displaced from the receptor in
the membranes of human placenta by different concentrations of bovine
and rabbit TC-Cbl as described elsewhere (26).
Determination of S-S Bonds in the Recombinant Bovine TC--
In
the initial step, 0.5 mg of the protein in 1 ml was dialyzed against
100 ml of 8 M urea, 0.2 M Tris, pH 8, at room
temperature for 2 days with one change to remove the endogenous Cbl.
Radioactive iodoacetate was added for determination of possible free SH
groups, and the mixture was incubated for 2 h. Urea and
iodoacetate were removed by dialysis against 1 liter of 0.1 M ammonium bicarbonate, pH 8, for 48 h with one
change. The final dialyzing buffer was 0.1 M
acetate-pyridine, pH 6.5, whereupon the denatured TC (expected to
retain the original pattern of S-S bridges) was subjected to digestion
with 60 µg of thermolysin (50 °C, 4 h). The peptide mixture
was separated by HPLC, and the fractions containing disulfide bonds
were identified by amino acid analysis after performic acid oxidation. The detected fractions were additionally purified by HPLC,
sequenced on Protein Sequencer 477A (Perkin-Elmer), and analyzed by
matrix-assisted laser desorption ionization/time of flight mass
spectrometry on BiflexTM (Bruker-Frauzer Analytik) (see
Ref. 27 for more details).
Treatment of holo-TC with Dithiothreitol--
TC-bound Cbl was
converted to its cyano form (see "Spectral Measurements") to
prevent coordination of dithiothrietol in the form of
R-S Cloning of Bovine TC and Analysis of Its Sequence--
The
cDNA of TC was cloned from a bovine mammary gland cDNA library
and the deduced amino acid sequence of bovine TC is depicted in Fig.
1. The sequence showed 71% identity with
human TC, whereas similarity with HC and IF from different sources
varied in the range 21-25%. Bovine TC was characterized by a positive
net charge +10 because of a high number of Arg and Lys residues. The
net charge of human TC was, on the contrary, negative ( The Relative Level of TC in Different Bovine Tissues--
Northern
blot analysis was performed using both the TC-specific and Expression and Purification of Bovine TC--
Bovine TC was
expressed as a fusion protein mHX-TC and was detected by Western blot
employing an anti-Myc antibody (Fig.
3A). No TC expression was
found when the incubation media did not contain Cbl (data not shown).
Coomassie Blue staining of the crude cell-free supernatant after
SDS-electrophoresis (Fig. 3B, lane 1) revealed two major bands of 50 and 46 kDa, which were present in the partially purified CM-Sepharose fractions as well (Fig. 3B, lane
3). N-terminal sequences showed that the 50-kDa protein
corresponded to the immunoreactive form mHX-TC as detected by anti-Myc
antibody and the 46-kDa band corresponded to the mature TC. The 50-kDa
protein was still visible in the cell-free supernatant passed through
CM-Sepharose (Fig. 3B, lane 2).
The final product was obtained after cleavage of mHX fragment by factor
Xa, gel filtration on Sephacryl S-200, and concentration on
CM-Sepharose. The preparation consisted mainly of a 46-kDa TC (Fig.
3B, lane 4). Still, the N-terminal sequence
revealed the presence of two subforms: NI(C)EITEVD ...
and IEGRNI(C)EI ... (the TC residues are underlined).
The yield of the recombinant TC corresponded to 0.5-1 mg from 1 liter
of the incubation medium.
Verification of Structural and Functional Properties of the
Recombinant TC--
The absorbance spectra showed that the Determination of S-S Bridges--
No free SH groups were detected
in the denaturated TC as judged from the lack of an incorporated
HOOCCH2 group after treatment with iodoacetate. Three pairs
of the peptides connected with S-S bonds were obtained after
separation of thermolysin-digested TC by HPLC. Analysis by mass
spectrometry and amino acid sequence identified these peptides as: 1)
NI(C) and LGTA(C), 2) FS(C) and L(C), and 3) LRAN(C)EF and
ISPD(C)QA. The location of the S-S bridges along the TC sequence is
shown in Fig. 6.
A number of peptides were purified after treatment of the native TC
isolated from bovine milk with trypsin. The following Cys-containing
fragments co-eluted during HPLC: 1-15 and 218-254, 96-104 and
285-298, and 134-160 and 161-199. It indirectly testifies that they
are bound together, and the pattern of S-S bridges in the native TC is
the same as in the recombinant TC.
Intact S-S bonds are required for retention of Cbl in the TC-Cbl
complex. Dialysis of TC-Cbl-CN against dithiothreitol-containing buffer
was accompanied by the removal of the endogenous Cbl, Fig. 4A.
Spectral Studies of the
Conversion of the TC-Cbl spectrum during substitution of endogenous
The analogous experiment was performed with protein-free
Cbl-OH2, which has a predominant base-on structure in water
solution (29). The response to the added azide occurred immediately
after mixing of the reagents (t1/2 < 0.1 min) for
all concentrations used (Fig. 4C). The amplitude changes were much less than those for TC-Cbl, and the half-effect occurred already at N3 A TC-cDNA was obtained from a bovine mammary gland cDNA
library and used for expression of the recombinant TC in yeast. The choice of the cDNA library was based on our previous observation of
a high TC concentration in bovine milk (3 nM) when compared with bovine plasma (0.2 nM) (10). Nevertheless, synthesis
of the TC-mRNA in bovine mammary glands was lower than in other
tissues, especially kidney, lymphatic nodes, and liver (Fig.
2A). This may suggest that TC in bovine milk does not
originate from mammary glands but is transported from blood to the milk
through the mammary gland epithelium.
Alignment of seven Cbl-binders bovine and human TCs (present work and
Refs. 32 and 33); human and porcine HCs (34, 35); human, mouse, and rat
IFs (36-38) revealed positions of the conservative residues identical
in all proteins (Fig. 1). The earlier analysis of such a kind (32, 33)
resulted in identification of 7 and 6 regions of high similarity
according to the alignment of three and four Cbl-binding proteins,
respectively. Our data sustain conserved structure of four regions, II,
III, IV, and V, according to the nomenclature used by Li et
al. (33). All these segments are situated in the middle part of
the sequence (Fig. 6) and may be responsible for Cbl binding. It is
interesting that the nonconservative domains in bovine TC were
particularly susceptible to trypsin (Fig. 6), suggesting that these
regions are exposed to the external medium.
Recombinant bovine TC was successfully expressed in yeast and the
pattern of the disulfide bridges was established (Fig. 6). The
organization of S-S bonds in the recombinant bovine TC was identical
to that deduced for the natural TC from bovine milk. The six Cys
residues, found in bovine TC and involved in S-S bonding, were present
in three known IFs (36-38), as well as in human TC (32, 33) and human
HC (34). Positions of these residues along the sequences varied
insignificantly, and one can assume the pattern of S-S bonds between
six of the Cys-residues (Cys1-Cys5,
Cys2-Cys6, Cys3-Cys4)
to be general for all Cbl binders. The absence of free SH groups in
human IF (39) supports the above suggestion. Three S-S bridges between
the distant Cys residues embrace the possible sites of Cbl binding and
may ensure extraordinary stability of the Cbl-protein complexes
observed for TC, IF, and HC (1-4, 11-13). Liberation of the
endogenous Cbl from bovine TC in the presence of an S-S reducing
compound demonstrates functional importance of the disulfide bonds.
The absorbance spectra of TC-Cbl treated with azide gave some evidence
for a significant deformation in the Cbl molecule when bound to bovine
TC. Remarkable perturbations in the typical absorbance spectrum of Cbl,
evoked by coordination of azide to Co2+ in the upper axial
position ( The binding of Cbl to bovine TC decreased the mobility of the In conclusion, we have expressed functional bovine TC in yeast
P. pastoris and performed structural and
functional analysis of the isolated recombinant protein. The
established pattern of S-S bridges in bovine TC seems to be general
for other known Cbl carriers. Protective influence of TC, imposed on
Co2+-coordinated upper group of Cbl, was revealed during
H2O
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-actin
(a control of RNA quantity on a Northern blot) was deduced from
comparison of the conservative stretches in cDNAs of
different species: CAACGGCTCCGGCATGTGCA, CCGGCTTCGCGGGCGACGAT, AAGATGACCCAGATCATGTT, and GATGATGATATCGCCGCGCTCGTCGTC.
gt11
(CLONTECH) was plated and screened with a
32P-labeled human TC cDNA probe according to the
standard procedure (22). Positive clones were propagated and then
rescreened with 32P-labeled bovine TC oligonucleotides
corresponding to different stretches in the sequence. It resulted in
identification and isolation of two cDNA clones with long
overlapping TC fragments. They were subcloned into the EcoRI
site of the Bluescript KS-II plasmid (Stratagene) and sequenced
on ABI-Prism Genetic Analyzer (Perkin-Elmer).
-actin. The bands were visualized after exposure with intensifying
screen for 2 weeks at
70 °C.
-LB. It was derived in our laboratory from pPIC
A
(Invitrogen) by introduction of the Myc sequence, a His tag, and a
factor Xa cleavage site before the protein sequence, for
more details see "Results."
0.65 (
362
30,000 M
1 cm
1).
-group
(H2O) in Cbl-OH2 and TC-Cbl-OH2 by
azide was followed according to the spectral changes developing at
37 °C in 0.5 M Pi buffer, pH 7.5, in the presence of different concentrations of sodium azide. The amplitudes (A363
A330) were
plotted versus time to calculate the maximal values at
t
.
-H2O in TC-Cbl-OH2 by
cyanide was carried out for 5 h under analogous conditions in the
presence of 10 mM KCN. The excess of KCN was removed by dialysis.
362
30,000 M
1 cm
1 (see "Spectral
Measurements") or by the isotope dilution method (24) employing human
IF as the binding protein.
to Co2+. Then, the sample was treated
with 10 mM dithiothreitol for 3 h at 37 °C and
dialyzed for 24 h at room temperature against 0.5 M
Pi buffer, pH 7.5, with 5 mM dithiothreitol.
Analogous procedure was carried out with the control sample where the
additive was H2O. Absorbance spectra were recorded after
dialysis in both preparations.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
6). Peptides, obtained after trypsin cleavage of the native TC-Cbl from bovine milk,
showed sequences identical to those predicted by cDNA. High recovery of the peptides was observed for the protein domains 16-41
and 285-347.

View larger version (54K):
[in a new window]
Fig. 1.
Nucleotide and amino acid sequences of bovine
TC. The conservative residues (*) identical in all
Cbl-transporting proteins were established according to alignment of
bovine TC with several Cbl binders: human TC (32, 33), human HC (34),
porcine HC (35), human IF (36), rat IF (37), and mouse IF (38). Four
distinct clusters of high similarity (30-50%) were detected: 85-98
(29%), 137-147 (40%), 178-190 (54%), and 268-288 (35%). Two
regions of low similarity are present between residues 10-80 and
290-340. The potential glycosylation site ( ...
N76 ... ) is shown as a symbol (
). The sequence was
submitted to the GenBankTM Database with accession number
AF121289.
-actin
radioactive probes (Fig. 2). The highest
expression of TC-mRNA (
1.9 kilobases) was associated with bovine
kidney followed by lymphatic nodes and the liver, whereas bovine
mammary gland contained a relatively low amount of
TC-mRNA.

View larger version (124K):
[in a new window]
Fig. 2.
Northern blot analysis of the total RNA
isolated from different bovine tissues. Lane 1, mammary
glands; lanes 2, and 3, lymphatic nodes;
lane 4, spleen; lane 5, intestine; lane
6, lung; lane 7, liver; and lane 8, kidney.
A, the samples were hybridized to a 32P-labeled
probe for bovine TC-cDNA. B, the samples were hybridized
to a 32P-labeled probe for
-actin. Hybridization was
carried out with the membrane from A stripped beforehand
from the TC-specific probe.

View larger version (63K):
[in a new window]
Fig. 3.
Electrophoretic analysis on different stages
of purification of the recombinant bovine TC. A,
detection of the recombinant fusion protein mHX-TC on Western blot by
anti-Myc antibody. Lane 1, 20 µl of the cell
supernatant concentrated after ammonium sulfate precipitation;
lane 2, 1 µg of the preparation obtained after
His6-specific purification; lane 3, 1 µg of
the TC preparation purified on CM-Sepharose. B, Coomassie
Blue-stained SDS-electrophoresis. Lane 1, 20 µl
of the concentrated cell supernatant; lane 2, 20 µl of the
same supernatant passed through CM-Sepharose; lane 3, 3 µg
of the TC-containing fraction obtained after CM-Sepharose purification
of the cell supernatant. The N-terminal sequences of the major 50 kDa
and 46 kDa proteins corresponded to mHX-TC and TC, respectively.
Lane 4, 6 µg of the final preparation of the
recombinant bovine TC. The N-terminal sequence of the 46-kDa protein
revealed an equimolar mixture of IEGR-TC and TC.
-peak in
the free aqua Cbl (352 nm) shifted to longer wavelength (362 nm) and
intensified after binding to TC (Fig.
4A). Conversion of TC-bound
Cbl to its cyano form caused additional amplification of the
-peak.
The same effects were observed earlier for human TC-Cbl (18) and rabbit
TC-Cbl (21). The preparation contained 1 mol of the endogenous Cbl/mol
of the protein as judged from the absorbance ratio,
A280/A362
2, attributed to the saturated Cbl binders (17, 18, 21, 23). The stability
of the TC-Cbl complex was analyzed according to the rate constant of
its decomposition. A slow exponential decay of TC-Cbl* (Fig.
5A) was observed with the rate
constant k
1.6 × 10
4
min
1 at 37 °C. The recombinant bovine TC, saturated
with Cbl, was able to bind to the specific TC receptor in membranes of
human placenta (2, 4, 24) with the same efficiency as TC-Cbl purified
from rabbit plasma (Fig. 5B).

View larger version (25K):
[in a new window]
Fig. 4.
Spectral properties of the recombinant bovine
TC (37 °C, 0.5 M Pi buffer, pH 7.5.).
A, absorbance spectra of Cbl-OH2 (spectrum
1), TC-Cbl-OH2 (spectrum 2), TC-Cbl-CN
(spectrum 3), TC-Cbl-CN treated with
dithiothreitol and dialyzed (spectrum 4), all
36 µM. B, spectral response of
TC-Cbl-OH2 (36 µM) to the added azide.
Spectra at 2 mM azide were recorded after 5, 15, 30, 60, 120, 180, and 240 min of incubation. The presented spectrum at 70 mM azide was recorded after 360 min of incubation, when the
reaction was practically accomplished. C, changes in the
spectrum of Cbl-OH2 (36 µM) in response to
azide added at the following concentrations: 0, 12, 25, 40, 50, 80, 120, 180, 250, 500, and 2000 µM. There was no difference
between the records after 1 and 60 min of incubation at the same
N3
. D, relative
spectral changes obtained for Cbl and TC-Cbl at different azide
concentrations. The apparent Kd was 0.046 mM for Cbl-N3
and 0.84 mM for TC-Cbl-N3
.

View larger version (15K):
[in a new window]
Fig. 5.
Ligand and receptor binding properties of the
recombinant bovine TC. A, liberation of the radioactive
ligand (Cbl*) from TC-Cbl* at 37 °C. Remaining concentration of
TC-Cbl* was followed in time in the presence of a 100-fold excess of
the unlabeled vitamin B12 (
) or without additives (
).
Subtraction of the first chart from the second reveals appearance of
free Cbl* in the medium (
). The dependence of TC-Cbl* and Cbl* on
time was fitted by equations: 0.43 × exp(
0.00017t) and 0.12 + 0.44 × (1
exp(
0.000155t)), respectively. The rate
constant of Cbl* liberation can be estimated as k
1.6 × 10
4 min
1. B, binding of the
recombinant bovine TC-Cbl (
) and rabbit TC-Cbl (
) to the
TC-specific receptor in the membranes of human placenta. The assayed
proteins displaced the radioactive tracer from the receptor at
increasing concentrations of bovine TC-Cbl (bTC) and rabbit
TC-Cbl (rTC).

View larger version (10K):
[in a new window]
Fig. 6.
S-S bridges (
) between Cys residues
(closed circle) in the molecule of the recombinant
bovine TC. The same motif of the conservative Cys residues was
found in human, mouse, and rat IFs, which testifies for analogous
organization of their S-S bridges. Human TC and HC have two additional
Cys residues (shaded circle), which provide a condition for
an additional S-S bridge in each protein. Conservative regions are
indicated as dark boxes. Nonconservative domains are shown
as light boxes. Stretches particularly susceptible to
trypsin are indicated with arrows according to the number of
cuts.
-group Exchange in the Free and TC-bound
Cbl--
We investigated the exchange of the original
Co2+-coordinated
-group (H2O) with an
external ligand in TC-Cbl. Sodium azide was chosen as a possible probe
for the "base-on" and "base-off" structure of Cbl (29).
Significant perturbations in the spectrum of the protein-bound Cbl upon
azide coordination, accompanied by the appearance of a
2-peak, are believed to be an evidence in favor of the
base-off structure of Cbl (28, 30).
-H2O by external N3
developed exponentially in time (Fig. 4B). The amplitude and t1/2 of the reaction increased at high concentration
of azide: t1/2 = 15 min at
N3
= 0.5 mM,
t1/2 = 60 min at N3
= 10-70 mM (37 °C). Strong expression of the
2-peak at 343 nm was achieved at saturating
concentrations of azide. The observed process was consistent with the
two step scheme where the first stage is shifted to the left
(k
1/k+1 > 50) and is rate-limiting.
The form TC-Cbl' corresponds to an intermediate capable of azide
binding. Increasing concentrations of
N3
reverse the balance in favor of
TC-Cbl-N3, and it takes a longer time to accomplish
equilibration at high N3
. The scheme
simplifies to TC-Cbl-OH2
TC-Cbl-N3 at
saturating concentration of azide when the measured rate coefficient
kobs = 0.012 min
1 should be close
to k+1. The amplitude of the spectral changes (calculated for t
) depended hyperbolically on azide
concentration with the apparent dissociation constant
Kd = 0.84 mM (Fig.
4D).
0.06 mM.
It was comparable to concentration of the binding sites, Cbl = 0.036 mM, and required a fit according to the "square root" equation (31) with Kd = 0.046 mM.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
), are believed to be associated with substitution of
dimethylbenzimidazol in the lower axial position (
) by another
ligand (28, 30). A His residue coordinates to Co2+ and
substitutes dimethylbenzimidazol in many enzymes (29), which is
supposed to be important for stabilization and destabilization of
the functional
-group during catalysis. Disruption or weakening of
the dimethylbenzimidazol-Co2+ bond may also take place in
bovine TC-Cbl.
-group
in the Cbl molecule according to velocities of H2O
azide exchange. A similar effect had been observed for another protein
HC-Cbl (40, 41). The mechanism of protein-enforced partial
immobilization of the
-group is not clear. The Cbl-binding proteins
can, for example, poise some "
-stable" conformation of Cbl and
restrict its transition to another "
-mobile" structure. One
cannot exclude complete encapsulation of Cbl inside the protein molecule when the "open" conformation of TC-Cbl is unfavorable. Both suggestions can be described by Scheme 1, and clarification of
this question requires some additional work. Anyway, the physiological role of such a protection is consistent with safe transportation of the
active cofactor when circulating in blood bound to TC and HC. Another
observation concerns the affinity of different
-groups to the TC-Cbl
complex. Thus, the ability of azide to compete with water significantly
decreased after the binding of Cbl to TC (Fig. 4C), which
may suggest Co2+-coordinated H2O to be more
preferable than Co2+-coordinated
N3
.
azide exchange. The process was accompanied by
essential spectral perturbations presumably caused by significant
deformations of Cbl bound to bovine TC.
| |
ACKNOWLEDGEMENTS |
|---|
We greatly appreciate the perfect technical assistance of M. S. Rasmussen and A. L. Christensen. We are grateful to A. Madsen, MD Foods Research and Development Center, Brabrand, Denmark for the supply of bovine milk samples.
| |
FOOTNOTES |
|---|
* This work has been supported by the Danish Research Councils (FELFO).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF121289.
¶ To whom correspondence should be addressed. Tel.: 45 86 20 20 00; Fax: 45 86 13 65 97.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: TC, transcobalamin; Cbl, cobalamin; Cbl*, [57Co]cyanocobalamin; HC, haptocorrin; IF, intrinsic factor; Pi buffer, NaH2PO4/Na2HPO4 buffer; HPLC, high pressure liquid chromatography; Cbl-OH2, Cbl-CN, Cbl-N3, aquo-, cyano-, azidocobalamin; mHX-TC, fusion protein composed of Myc site, His6 peptide, recognition site for factor Xa, and mature TC.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Allen, R. H. (1975) Prog. Hematol. 9, 57-84[Medline] [Order article via Infotrieve] |
| 2. | Rothenberg, S. P., and Quadros, E. V. (1995) Bailliere's Clin. Haematol. 8, 499-514[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Nicolas, J. P., and Gueant, J. L. (1995) Bailliere's Clin. Haematol. 8, 515-531[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Nexø, E. (1998) in Vitamin B12 and B12-Proteins (Kräutler, B. , Angoni, D. , and Golding, B. T., eds) , pp. 461-475, Wiley-VCH, Weinheim, Germany |
| 5. | Hall, C. A., and Begley, J. A. (1977) Am. J. Hum. Genet. 29, 619-626[Medline] [Order article via Infotrieve] |
| 6. | Katz, M., Mehlman, C. S., and Allen, R. H. (1974) J. Clin. Invest. 53, 1274-1283 |
| 7. |
Li, N.,
Rosenblatt, D. S.,
Kamen, B. A.,
Seetharam, S.,
and Seetharam, B.
(1994)
Hum. Mol. Genet.
3,
1835-1840 |
| 8. | Nexø, E. (1990) Biomedicine and Physiology of Vitamin B12 , pp. 353-358, The Children's Medical Charity, London |
| 9. |
Burger, R. L.,
and Allen, R. H.
(1974)
J. Biol. Chem.
249,
7220-7227 |
| 10. | Fedosov, S. N., Petersen, T. E., and Nexø, E. (1996) Biochim. Biophys. Acta 1292, 113-119[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Kolhouse, J. F., and Allen, R. H. (1977) J. Clin. Invest. 60, 1381-1392 |
| 12. | Marchaj, A., Jacobsen, D. W., Savon, S. R., and Brown, K. L. J. (1995) Am. Chem. Soc. Symp. Ser. 117, 11640-11646 |
| 13. | Fedosov, S. N., Petersen, T. E., and Nexø, E. (1995) Biochemistry 34, 16082-16087[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | Stupperich, E., and Nexø, E. (1991) Eur. J. Biochem. 199, 299-303[Medline] [Order article via Infotrieve] |
| 15. | Quadros, E. V., Rothenberg, S. P., and McLoughlin, P. (1996) Biochem. Biophys. Res. Commun. 222, 149-154[CrossRef][Medline] [Order article via Infotrieve] |
| 16. |
Tang, L. H.,
Chokshi, H.,
Hu, C. B.,
Gordon, M. M.,
and Alpers, D. H.
(1992)
J. Biol. Chem.
267,
22982-22986 |
| 17. | VanKapel, J., Loef, B. G., Lindemans, J., and Abels, J. (1981) Biochim. Biophys. Acta 676, 307-313[Medline] [Order article via Infotrieve] |
| 18. |
Quadros, E. V.,
Rothenberg, S. P.,
Pan, Y. C.,
and Stein, S.
(1986)
J. Biol. Chem.
261,
15455-15460 |
| 19. | Gordon, M., Chokshi, H., and Alpers, D. H. (1992) Biochim. Biophys. Acta 1132, 276-283[Medline] [Order article via Infotrieve] |
| 20. |
Quadros, E. V.,
Sai, P.,
and Rothenberg, S. P.
(1993)
Blood
81,
1239-1245 |
| 21. | Nexø, E., Olesen, H., Bucher, D., and Thomsen, J. (1977) Biochim. Boiphys. Acta 494, 395-402[Medline] [Order article via Infotrieve] |
| 22. | Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. (1999) Current Protocols in Molecular Biology , pp. 1.01-7.7.23, John Wiley & Sons, Inc., New York |
| 23. | Scopes, R. K. (1974) Anal. Biochem. 59, 277-282[CrossRef][Medline] [Order article via Infotrieve] |
| 24. | Nexø, E., and Gimsing, P. (1981) Scand. J. Clin. Lab. Invest. 41, 465-468[Medline] [Order article via Infotrieve] |
| 25. |
Gottlieb, C.,
Lau, K-S.,
Wasserman, L. R.,
and Herbert, W.
(1965)
Blood
25,
875-884 |
| 26. | Nexø, E., and Hollenberg, M. D. (1980) Biochim. Biophys. Acta 628, 190-200[Medline] [Order article via Infotrieve] |
| 27. | Rasmussen, J. T., Berglund, L., Rasmussen, M. S., and Petersen, T. E. (1998) Eur. J. Biochem 257, 488-494[Medline] [Order article via Infotrieve] |
| 28. | Nexø, E., and Olesen, H. (1976) Biochim. Biophys. Acta 446, 143-150[Medline] [Order article via Infotrieve] |
| 29. | Kräutler, B. (1998) Vitamin B12 and B12-Proteins , pp. 3-43, Wiley-VCH, Weinheim, Germany |
| 30. | Firth, R. A., Hill, H. A. O., Pratt, J. M., Williams, R. J. P., and Jackson, W. R. (1967) Biochemistry 6, 2178-2188[CrossRef][Medline] [Order article via Infotrieve] |
| 31. | Fedosov, S. N., Belousova, L. V., and Plesner, I. (1993) Biochim. Biophys. Acta 1153, 322-330[Medline] [Order article via Infotrieve] |
| 32. |
Platica, O.,
Janeczko, R.,
Quadros, E. V.,
Regec, A.,
Romain, R.,
and Rothenberg, S. P.
(1991)
J. Biol. Chem.
266,
7860-7863 |
| 33. | Li, N., Seetharam, S., Lindemans, J., Alpers, D. H., Arwert, F., and Seetharam, B. (1993) Biochim. Biophys. Acta 1172, 21-30[Medline] [Order article via Infotrieve] |
| 34. |
Johnston, J.,
Bollekens, J.,
Allen, R. H.,
and Berliner, N.
(1989)
J. Biol. Chem.
264,
15754-15757 |
| 35. | Hewitt, J. E., Seetharam, B., Leykam, J., and Alpers, D. H. (1990) Eur. J. Biochem. 189, 125-130[Medline] [Order article via Infotrieve] |
| 36. | Hewitt, J. E., Gordon, M. M., Taggart, R. T., Mohandas, T. K., and Alpers, D. H. (1991) Genomics 10, 432-440[CrossRef][Medline] [Order article via Infotrieve] |
| 37. |
Lorenz, R. G.,
and Gordon, J. I.
(1993)
J. Biol. Chem.
268,
26559-26570 |
| 38. |
Dieckgraefe, B. K.,
Seetharam, B.,
Banaszak, L.,
Leykam, J. F.,
and Alpers, D. H.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
46-50 |
| 39. |
Allen, R. H.,
and Mehlman, C. S.
(1973)
J. Biol. Chem.
248,
3660-3669 |
| 40. |
Brown, K. L.,
Brooks, H. B.,
Behnke, D.,
and Jacobsen, D. W.
(1991)
J. Biol. Chem.
266,
6737-6741 |
| 41. | Frisbie, S. M., and Chance, M. R. (1993) Biochemistry 32, 13886-13892[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
J. Brady, L. Wilson, L. McGregor, E. Valente, and L. Orning Active B12: A Rapid, Automated Assay for Holotranscobalamin on the Abbott AxSYM Analyzer Clin. Chem., March 1, 2008; 54(3): 567 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wuerges, G. Garau, S. Geremia, S. N. Fedosov, T. E. Petersen, and L. Randaccio Structural basis for mammalian vitamin B12 transport by transcobalamin PNAS, March 21, 2006; 103(12): 4386 - 4391. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Refsum, C. Johnston, A. B. Guttormsen, and E. Nexo Holotranscobalamin and Total Transcobalamin in Human Plasma: Determination, Determinants, and Reference Values in Healthy Adults Clin. Chem., January 1, 2006; 52(1): 129 - 137. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Fedosov, L. Berglund, N. U. Fedosova, E. Nexo, and T. E. Petersen Comparative Analysis of Cobalamin Binding Kinetics and Ligand Protection for Intrinsic Factor, Transcobalamin, and Haptocorrin J. Biol. Chem., March 15, 2002; 277(12): 9989 - 9996. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. NIELSEN, B. S. SØRENSEN, H. BIRN, E. I. CHRISTENSEN, and E. NEXØ Transcellular Transport of Vitamin B12 in LLC-PK1 Renal Proximal Tubule Cells J. Am. Soc. Nephrol., June 1, 2001; 12(6): 1099 - 1106. [Abstract] [Full Text] |
||||
![]() |
S. N. Fedosov, N. U. Fedosova, E. Nexo, and T. E. Petersen Conformational Changes of Transcobalamin Induced by Aquocobalamin Binding. MECHANISM OF SUBSTITUTION OF THE COBALT-COORDINATED GROUP IN THE BOUND LIGAND J. Biol. Chem., April 14, 2000; 275(16): 11791 - 11798. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||